Trading Window

MedPlus Health Services Limited September 28, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001 Bandra (East), Mumbai – 400 051 BSE Scrip Code Equity: 543427 NSE Symbol: MEDPLUS Dear Sir/ Madam, Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR ") and Trading Window Closure under SEBI (Prohibition of Insider Trading) Regulations, 2015 Pursuant to Regulation 29 read with Regulation 33 of the SEBI LODR, we would like to inform that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, October 27, 2026, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2026. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Conduct for Prevention of Insider Trading, the trading window for the Designated Persons of the Company and including their immediate relatives, will be closed from October 01, 2026, till 48 hours after declaration of Un-audited financial results of the Company for the quarter and half- year ended September 30, 2026. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. Thanking You Yours faithfully For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer ICSI M. No. F12400 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com